| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 147 | 2024 | 6010 | 7.680 |
Why?
|
| Air Pollution | 82 | 2024 | 2286 | 6.440 |
Why?
|
| Air Pollutants | 88 | 2023 | 2816 | 6.170 |
Why?
|
| Respiratory Sounds | 47 | 2022 | 696 | 5.450 |
Why?
|
| Particulate Matter | 80 | 2024 | 2529 | 5.300 |
Why?
|
| Air Pollution, Indoor | 49 | 2022 | 857 | 4.440 |
Why?
|
| Allergens | 61 | 2022 | 1320 | 4.280 |
Why?
|
| Environmental Exposure | 98 | 2023 | 4232 | 4.090 |
Why?
|
| Hypersensitivity | 29 | 2023 | 1102 | 2.860 |
Why?
|
| Endotoxins | 18 | 2017 | 527 | 2.560 |
Why?
|
| Dust | 32 | 2022 | 478 | 2.460 |
Why?
|
| Hypersensitivity, Immediate | 20 | 2019 | 337 | 2.320 |
Why?
|
| Prenatal Exposure Delayed Effects | 26 | 2021 | 2407 | 2.130 |
Why?
|
| Vehicle Emissions | 20 | 2022 | 665 | 2.100 |
Why?
|
| Fetal Blood | 28 | 2021 | 1318 | 2.050 |
Why?
|
| Immunoglobulin E | 32 | 2022 | 1463 | 1.960 |
Why?
|
| Schools | 25 | 2023 | 1432 | 1.750 |
Why?
|
| Maternal Exposure | 13 | 2021 | 961 | 1.560 |
Why?
|
| Environmental Monitoring | 27 | 2022 | 1413 | 1.560 |
Why?
|
| Inhalation Exposure | 15 | 2020 | 443 | 1.530 |
Why?
|
| Ozone | 22 | 2019 | 469 | 1.470 |
Why?
|
| Fluorocarbons | 11 | 2021 | 452 | 1.340 |
Why?
|
| Housing | 24 | 2022 | 664 | 1.330 |
Why?
|
| Fungi | 10 | 2022 | 326 | 1.310 |
Why?
|
| Eczema | 12 | 2012 | 231 | 1.250 |
Why?
|
| Blood Pressure | 15 | 2020 | 8551 | 1.250 |
Why?
|
| Particle Size | 28 | 2021 | 1639 | 1.240 |
Why?
|
| Antigens, Dermatophagoides | 13 | 2017 | 100 | 1.180 |
Why?
|
| Child | 156 | 2024 | 77637 | 1.130 |
Why?
|
| Respiratory Tract Infections | 9 | 2018 | 960 | 1.110 |
Why?
|
| Forced Expiratory Volume | 23 | 2023 | 1740 | 1.090 |
Why?
|
| Urban Health | 12 | 2017 | 547 | 1.090 |
Why?
|
| Child, Preschool | 106 | 2024 | 40964 | 1.040 |
Why?
|
| Urban Population | 29 | 2020 | 2021 | 1.020 |
Why?
|
| Food Hypersensitivity | 10 | 2022 | 622 | 1.010 |
Why?
|
| DNA Methylation | 17 | 2024 | 4286 | 1.010 |
Why?
|
| Alkanesulfonic Acids | 8 | 2021 | 180 | 0.970 |
Why?
|
| Interleukin-13 | 9 | 2017 | 389 | 0.970 |
Why?
|
| Heart Rate | 22 | 2021 | 4091 | 0.960 |
Why?
|
| Female | 296 | 2024 | 380020 | 0.920 |
Why?
|
| Environmental Pollutants | 10 | 2021 | 1179 | 0.920 |
Why?
|
| Arrhythmias, Cardiac | 11 | 2020 | 2267 | 0.880 |
Why?
|
| Cohort Studies | 90 | 2024 | 40545 | 0.880 |
Why?
|
| Male | 278 | 2024 | 349776 | 0.880 |
Why?
|
| Eicosapentaenoic Acid | 2 | 2018 | 581 | 0.880 |
Why?
|
| Humans | 405 | 2024 | 743811 | 0.870 |
Why?
|
| Oxidants, Photochemical | 6 | 2017 | 78 | 0.830 |
Why?
|
| Nasal Mucosa | 3 | 2021 | 372 | 0.820 |
Why?
|
| Pregnancy | 73 | 2024 | 29140 | 0.820 |
Why?
|
| Lung | 19 | 2023 | 9858 | 0.810 |
Why?
|
| Infant | 82 | 2022 | 35122 | 0.810 |
Why?
|
| Nitrogen Dioxide | 17 | 2024 | 490 | 0.790 |
Why?
|
| Electrocardiography, Ambulatory | 12 | 2009 | 585 | 0.780 |
Why?
|
| Docosahexaenoic Acids | 2 | 2018 | 877 | 0.750 |
Why?
|
| Inflammation | 16 | 2023 | 10629 | 0.740 |
Why?
|
| Seasons | 16 | 2019 | 1493 | 0.730 |
Why?
|
| Cats | 18 | 2017 | 986 | 0.730 |
Why?
|
| Nickel | 1 | 2020 | 130 | 0.730 |
Why?
|
| Carbon | 15 | 2024 | 686 | 0.710 |
Why?
|
| Infant, Newborn | 58 | 2023 | 25609 | 0.700 |
Why?
|
| Boston | 39 | 2020 | 9310 | 0.680 |
Why?
|
| Nitric Oxide | 8 | 2023 | 2132 | 0.660 |
Why?
|
| Vitamin D | 12 | 2023 | 3222 | 0.660 |
Why?
|
| Dietary Supplements | 8 | 2023 | 3292 | 0.630 |
Why?
|
| National Institute of Allergy and Infectious Diseases (U.S.) | 2 | 2017 | 62 | 0.630 |
Why?
|
| beta-Glucans | 2 | 2017 | 123 | 0.620 |
Why?
|
| Child Day Care Centers | 4 | 2005 | 123 | 0.610 |
Why?
|
| National Institute of Environmental Health Sciences (U.S.) | 1 | 2017 | 7 | 0.610 |
Why?
|
| Pest Control | 1 | 2017 | 30 | 0.600 |
Why?
|
| Hypertension | 7 | 2020 | 8480 | 0.590 |
Why?
|
| Exhalation | 4 | 2023 | 167 | 0.580 |
Why?
|
| RNA, Ribosomal, 16S | 7 | 2022 | 954 | 0.580 |
Why?
|
| Organizations, Nonprofit | 1 | 2017 | 104 | 0.570 |
Why?
|
| Caprylates | 5 | 2021 | 111 | 0.570 |
Why?
|
| Fetal Development | 5 | 2018 | 767 | 0.560 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 2 | 2017 | 314 | 0.560 |
Why?
|
| Humidity | 8 | 2015 | 197 | 0.550 |
Why?
|
| Linear Models | 22 | 2021 | 5952 | 0.550 |
Why?
|
| Longitudinal Studies | 35 | 2019 | 13980 | 0.540 |
Why?
|
| Brachial Artery | 3 | 2014 | 369 | 0.540 |
Why?
|
| Adolescent | 78 | 2023 | 85729 | 0.540 |
Why?
|
| Airway Obstruction | 2 | 2020 | 662 | 0.530 |
Why?
|
| Radioactivity | 3 | 2020 | 63 | 0.520 |
Why?
|
| Risk Factors | 74 | 2023 | 72252 | 0.520 |
Why?
|
| Prospective Studies | 56 | 2023 | 53250 | 0.500 |
Why?
|
| Cockroaches | 13 | 2017 | 96 | 0.500 |
Why?
|
| Respiratory Function Tests | 13 | 2020 | 1615 | 0.500 |
Why?
|
| Prediabetic State | 4 | 2021 | 499 | 0.490 |
Why?
|
| Cytokines | 12 | 2019 | 7324 | 0.480 |
Why?
|
| Body Mass Index | 17 | 2023 | 12718 | 0.470 |
Why?
|
| Obesity | 14 | 2021 | 12744 | 0.470 |
Why?
|
| Soot | 8 | 2022 | 232 | 0.460 |
Why?
|
| School Health Services | 1 | 2017 | 375 | 0.460 |
Why?
|
| Antigens, Fungal | 1 | 2013 | 70 | 0.460 |
Why?
|
| Sex Factors | 13 | 2021 | 10394 | 0.460 |
Why?
|
| Rhinitis, Allergic, Perennial | 3 | 2013 | 57 | 0.450 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 4 | 2016 | 3047 | 0.450 |
Why?
|
| Climate | 2 | 2013 | 147 | 0.450 |
Why?
|
| Dermatitis, Atopic | 4 | 2018 | 654 | 0.420 |
Why?
|
| Tobacco Smoke Pollution | 10 | 2018 | 816 | 0.420 |
Why?
|
| Leukocytes, Mononuclear | 10 | 2020 | 1836 | 0.410 |
Why?
|
| Adult | 117 | 2023 | 213889 | 0.410 |
Why?
|
| Temperature | 9 | 2022 | 2202 | 0.400 |
Why?
|
| Cardiovascular Diseases | 17 | 2020 | 15142 | 0.400 |
Why?
|
| Diabetes Mellitus, Type 2 | 12 | 2021 | 11729 | 0.400 |
Why?
|
| Skin Tests | 9 | 2017 | 613 | 0.400 |
Why?
|
| Breath Tests | 6 | 2023 | 280 | 0.390 |
Why?
|
| Drug Industry | 1 | 2017 | 746 | 0.380 |
Why?
|
| Eating | 1 | 2018 | 1536 | 0.380 |
Why?
|
| Cholecalciferol | 1 | 2016 | 536 | 0.380 |
Why?
|
| Vitamins | 4 | 2024 | 1622 | 0.380 |
Why?
|
| Dogs | 14 | 2017 | 3911 | 0.370 |
Why?
|
| Rhinitis | 3 | 2014 | 690 | 0.370 |
Why?
|
| Adiposity | 7 | 2021 | 1806 | 0.370 |
Why?
|
| Vasodilation | 2 | 2014 | 944 | 0.360 |
Why?
|
| Immunity, Active | 1 | 2009 | 60 | 0.360 |
Why?
|
| Cysteine Endopeptidases | 5 | 2017 | 563 | 0.350 |
Why?
|
| Adrenal Cortex Hormones | 3 | 2018 | 1854 | 0.350 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 4 | 2016 | 159 | 0.350 |
Why?
|
| Mites | 8 | 2017 | 43 | 0.350 |
Why?
|
| Massachusetts | 26 | 2021 | 8660 | 0.350 |
Why?
|
| Arsenic | 2 | 2024 | 328 | 0.350 |
Why?
|
| Epigenesis, Genetic | 8 | 2024 | 3645 | 0.350 |
Why?
|
| Child Development | 6 | 2019 | 2212 | 0.340 |
Why?
|
| Pregnancy Trimester, Second | 7 | 2020 | 732 | 0.340 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 2021 | 437 | 0.330 |
Why?
|
| Vital Capacity | 13 | 2019 | 925 | 0.330 |
Why?
|
| Overweight | 6 | 2021 | 2371 | 0.330 |
Why?
|
| Oxidative Stress | 6 | 2019 | 3082 | 0.330 |
Why?
|
| Air Pollutants, Radioactive | 2 | 2019 | 46 | 0.330 |
Why?
|
| United States | 43 | 2023 | 69859 | 0.320 |
Why?
|
| Fibrinogen | 2 | 2022 | 894 | 0.320 |
Why?
|
| Middle Aged | 79 | 2021 | 213241 | 0.320 |
Why?
|
| Follow-Up Studies | 26 | 2021 | 39001 | 0.320 |
Why?
|
| Bronchodilator Agents | 3 | 2013 | 502 | 0.320 |
Why?
|
| Oxygen | 2 | 2014 | 4189 | 0.310 |
Why?
|
| Respiratory Tract Diseases | 5 | 2017 | 722 | 0.310 |
Why?
|
| Morbidity | 10 | 2021 | 1768 | 0.310 |
Why?
|
| Socioeconomic Factors | 12 | 2023 | 7784 | 0.300 |
Why?
|
| Residence Characteristics | 10 | 2023 | 2050 | 0.300 |
Why?
|
| Life Style | 8 | 2021 | 3833 | 0.300 |
Why?
|
| Fatty Acids, Omega-3 | 5 | 2019 | 1344 | 0.300 |
Why?
|
| Sleep Apnea Syndromes | 2 | 2019 | 944 | 0.300 |
Why?
|
| Interferon-gamma | 7 | 2017 | 3205 | 0.300 |
Why?
|
| Blattellidae | 2 | 2013 | 2 | 0.290 |
Why?
|
| Cities | 8 | 2020 | 512 | 0.290 |
Why?
|
| Carbon Monoxide | 8 | 2019 | 531 | 0.290 |
Why?
|
| Mothers | 7 | 2023 | 2166 | 0.290 |
Why?
|
| Diet | 12 | 2020 | 7930 | 0.290 |
Why?
|
| Heart Conduction System | 2 | 2011 | 1047 | 0.290 |
Why?
|
| Aged | 64 | 2022 | 163178 | 0.290 |
Why?
|
| Maternal-Fetal Exchange | 5 | 2020 | 456 | 0.290 |
Why?
|
| Respiratory Hypersensitivity | 3 | 2013 | 273 | 0.290 |
Why?
|
| Spores, Fungal | 3 | 2019 | 94 | 0.280 |
Why?
|
| Alternaria | 2 | 2019 | 44 | 0.280 |
Why?
|
| Multivariate Analysis | 17 | 2019 | 12243 | 0.280 |
Why?
|
| Autonomic Nervous System | 6 | 2017 | 671 | 0.270 |
Why?
|
| Infant Food | 2 | 2005 | 141 | 0.270 |
Why?
|
| Aged, 80 and over | 30 | 2020 | 57744 | 0.270 |
Why?
|
| Milk | 3 | 2022 | 449 | 0.270 |
Why?
|
| Gestational Age | 7 | 2023 | 3488 | 0.270 |
Why?
|
| Endocrine Disruptors | 2 | 2019 | 237 | 0.260 |
Why?
|
| RNA, Bacterial | 2 | 2019 | 390 | 0.260 |
Why?
|
| Single-Blind Method | 4 | 2017 | 1586 | 0.260 |
Why?
|
| Bacteria | 4 | 2019 | 2112 | 0.260 |
Why?
|
| Ohio | 4 | 2014 | 337 | 0.260 |
Why?
|
| Ventricular Dysfunction | 1 | 2006 | 143 | 0.260 |
Why?
|
| Hypotension | 1 | 2011 | 884 | 0.260 |
Why?
|
| Bayes Theorem | 7 | 2021 | 2307 | 0.260 |
Why?
|
| Body Weights and Measures | 2 | 2017 | 211 | 0.260 |
Why?
|
| Leukocytes | 1 | 2013 | 2044 | 0.260 |
Why?
|
| Cross-Over Studies | 9 | 2017 | 2029 | 0.250 |
Why?
|
| Accidents, Occupational | 2 | 2000 | 251 | 0.250 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2006 | 319 | 0.250 |
Why?
|
| Animals | 55 | 2022 | 168660 | 0.250 |
Why?
|
| Epigenomics | 3 | 2019 | 903 | 0.250 |
Why?
|
| Sex Characteristics | 3 | 2016 | 2583 | 0.250 |
Why?
|
| Logistic Models | 17 | 2016 | 13404 | 0.250 |
Why?
|
| Pneumonia | 2 | 2016 | 2133 | 0.240 |
Why?
|
| Blood Pressure Determination | 2 | 2020 | 633 | 0.240 |
Why?
|
| Prevalence | 17 | 2023 | 15211 | 0.240 |
Why?
|
| Interleukin-6 | 3 | 2017 | 3208 | 0.240 |
Why?
|
| Metabolome | 3 | 2022 | 894 | 0.240 |
Why?
|
| Weather | 5 | 2016 | 228 | 0.240 |
Why?
|
| Automobile Driving | 1 | 2009 | 430 | 0.240 |
Why?
|
| Spirometry | 8 | 2022 | 863 | 0.240 |
Why?
|
| Acculturation | 1 | 2005 | 182 | 0.230 |
Why?
|
| Hyperemia | 2 | 2016 | 225 | 0.230 |
Why?
|
| Feeding Behavior | 4 | 2017 | 3187 | 0.230 |
Why?
|
| Fishes | 2 | 2013 | 569 | 0.230 |
Why?
|
| Phenotype | 9 | 2022 | 16361 | 0.230 |
Why?
|
| Dyspnea | 3 | 2014 | 1303 | 0.230 |
Why?
|
| Sleep | 4 | 2019 | 4619 | 0.230 |
Why?
|
| Nitrogen Oxides | 4 | 2017 | 129 | 0.230 |
Why?
|
| Stress, Psychological | 4 | 2021 | 4245 | 0.230 |
Why?
|
| Lymphocyte Activation | 10 | 2019 | 5524 | 0.230 |
Why?
|
| Pyroglyphidae | 3 | 2009 | 88 | 0.230 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2011 | 1837 | 0.230 |
Why?
|
| Decanoic Acids | 2 | 2021 | 67 | 0.220 |
Why?
|
| Antioxidants | 2 | 2013 | 1658 | 0.220 |
Why?
|
| Fatty Acids, Omega-6 | 3 | 2011 | 227 | 0.220 |
Why?
|
| Odds Ratio | 16 | 2022 | 9848 | 0.220 |
Why?
|
| Mice | 16 | 2017 | 81154 | 0.220 |
Why?
|
| Birth Weight | 8 | 2021 | 2069 | 0.220 |
Why?
|
| Insect Proteins | 2 | 2006 | 255 | 0.220 |
Why?
|
| Parents | 8 | 2018 | 3403 | 0.220 |
Why?
|
| Egg Hypersensitivity | 1 | 2022 | 44 | 0.210 |
Why?
|
| Heart Diseases | 2 | 2013 | 2789 | 0.210 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 2003 | 118 | 0.210 |
Why?
|
| Emigration and Immigration | 1 | 2005 | 402 | 0.210 |
Why?
|
| Endogenous Retroviruses | 1 | 2023 | 112 | 0.210 |
Why?
|
| CpG Islands | 4 | 2019 | 1170 | 0.210 |
Why?
|
| Folic Acid | 3 | 2017 | 1293 | 0.210 |
Why?
|
| Sulfates | 5 | 2017 | 390 | 0.210 |
Why?
|
| Sulfur Dioxide | 6 | 2014 | 177 | 0.210 |
Why?
|
| Beta Particles | 2 | 2020 | 50 | 0.210 |
Why?
|
| Rodent Control | 1 | 2021 | 15 | 0.200 |
Why?
|
| Peak Expiratory Flow Rate | 2 | 2016 | 141 | 0.200 |
Why?
|
| Young Adult | 29 | 2023 | 56392 | 0.200 |
Why?
|
| Myocardial Ischemia | 2 | 2009 | 2150 | 0.200 |
Why?
|
| Fetal Growth Retardation | 2 | 2016 | 566 | 0.200 |
Why?
|
| Child Welfare | 2 | 2004 | 523 | 0.200 |
Why?
|
| Milk Hypersensitivity | 1 | 2022 | 76 | 0.200 |
Why?
|
| Sphingolipids | 2 | 2022 | 159 | 0.200 |
Why?
|
| Immunity, Innate | 2 | 2011 | 2961 | 0.200 |
Why?
|
| Diabetes Complications | 1 | 2008 | 1360 | 0.190 |
Why?
|
| Environmental Health | 4 | 2019 | 278 | 0.190 |
Why?
|
| Puberty | 1 | 2004 | 490 | 0.190 |
Why?
|
| Genome-Wide Association Study | 7 | 2023 | 12259 | 0.190 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2022 | 707 | 0.190 |
Why?
|
| Lymphocytes | 4 | 2019 | 2615 | 0.190 |
Why?
|
| Glutathione Transferase | 3 | 2013 | 595 | 0.190 |
Why?
|
| Regression Analysis | 13 | 2016 | 6457 | 0.190 |
Why?
|
| Incidence | 16 | 2024 | 20948 | 0.190 |
Why?
|
| Cross-Sectional Studies | 21 | 2021 | 25032 | 0.190 |
Why?
|
| gamma-Tocopherol | 1 | 2020 | 31 | 0.190 |
Why?
|
| Pregnancy Trimesters | 2 | 2019 | 192 | 0.180 |
Why?
|
| Antigens, Plant | 5 | 2004 | 86 | 0.180 |
Why?
|
| Decompression Sickness | 1 | 2000 | 12 | 0.180 |
Why?
|
| Metals, Heavy | 1 | 2021 | 139 | 0.180 |
Why?
|
| Breast Feeding | 7 | 2018 | 1338 | 0.180 |
Why?
|
| Diving | 1 | 2000 | 39 | 0.180 |
Why?
|
| Lactococcus | 1 | 2019 | 3 | 0.180 |
Why?
|
| Gram-Negative Bacteria | 3 | 2010 | 271 | 0.180 |
Why?
|
| Population Surveillance | 5 | 2019 | 2614 | 0.180 |
Why?
|
| Snoring | 1 | 2021 | 191 | 0.180 |
Why?
|
| Mexico | 9 | 2013 | 689 | 0.180 |
Why?
|
| Inflammation Mediators | 3 | 2017 | 1888 | 0.180 |
Why?
|
| Diabetes, Gestational | 3 | 2020 | 1184 | 0.180 |
Why?
|
| Actinomycetales | 1 | 2019 | 31 | 0.180 |
Why?
|
| alpha-Tocopherol | 1 | 2020 | 127 | 0.180 |
Why?
|
| Aspartic Acid Endopeptidases | 2 | 2017 | 311 | 0.170 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2022 | 1159 | 0.170 |
Why?
|
| Atrial Fibrillation | 5 | 2022 | 5033 | 0.170 |
Why?
|
| Gram-Positive Bacteria | 2 | 2010 | 185 | 0.170 |
Why?
|
| Health Services | 2 | 2017 | 758 | 0.170 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2019 | 571 | 0.170 |
Why?
|
| Environmental Illness | 1 | 2019 | 34 | 0.170 |
Why?
|
| Trace Elements | 1 | 2020 | 197 | 0.170 |
Why?
|
| Budesonide | 2 | 2013 | 154 | 0.170 |
Why?
|
| Vitamin B 6 | 2 | 2017 | 236 | 0.170 |
Why?
|
| Biomass | 1 | 2019 | 125 | 0.170 |
Why?
|
| Sulfur | 1 | 2019 | 166 | 0.170 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2011 | 4386 | 0.160 |
Why?
|
| Dietary Fats | 3 | 2018 | 2016 | 0.160 |
Why?
|
| Proteobacteria | 1 | 2018 | 45 | 0.160 |
Why?
|
| Social Class | 3 | 2005 | 1997 | 0.160 |
Why?
|
| Fatty Acids | 2 | 2006 | 1809 | 0.160 |
Why?
|
| Age Factors | 15 | 2021 | 18355 | 0.160 |
Why?
|
| Time Factors | 22 | 2020 | 40038 | 0.160 |
Why?
|
| Pregnancy Complications | 5 | 2019 | 2861 | 0.160 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2018 | 546 | 0.160 |
Why?
|
| Poverty | 6 | 2023 | 2660 | 0.160 |
Why?
|
| Oxidants | 1 | 2018 | 164 | 0.160 |
Why?
|
| Caffeine | 1 | 2022 | 699 | 0.160 |
Why?
|
| Masks | 1 | 2020 | 197 | 0.160 |
Why?
|
| Exercise Test | 2 | 2005 | 2074 | 0.160 |
Why?
|
| Proteoglycans | 3 | 2017 | 837 | 0.160 |
Why?
|
| Immunization | 3 | 2017 | 1255 | 0.160 |
Why?
|
| Risk Assessment | 16 | 2018 | 23327 | 0.160 |
Why?
|
| Climate Change | 1 | 2023 | 418 | 0.160 |
Why?
|
| Consensus Development Conferences, NIH as Topic | 1 | 2017 | 28 | 0.150 |
Why?
|
| Violence | 1 | 2004 | 909 | 0.150 |
Why?
|
| Age Distribution | 5 | 2003 | 2899 | 0.150 |
Why?
|
| Netherlands | 2 | 2021 | 2170 | 0.150 |
Why?
|
| Triclosan | 1 | 2017 | 55 | 0.150 |
Why?
|
| Interleukin-10 | 3 | 2008 | 1200 | 0.150 |
Why?
|
| Vitamin B 12 | 2 | 2017 | 527 | 0.150 |
Why?
|
| Pandemics | 3 | 2023 | 8385 | 0.150 |
Why?
|
| Fund Raising | 1 | 2017 | 47 | 0.150 |
Why?
|
| Wood | 1 | 2017 | 89 | 0.150 |
Why?
|
| Metabolomics | 3 | 2022 | 1487 | 0.150 |
Why?
|
| Genetic Association Studies | 2 | 2020 | 2703 | 0.150 |
Why?
|
| Parabens | 1 | 2017 | 108 | 0.140 |
Why?
|
| Confidence Intervals | 5 | 2017 | 2971 | 0.140 |
Why?
|
| Pregnancy Trimester, First | 4 | 2019 | 853 | 0.140 |
Why?
|
| Heating | 1 | 2017 | 97 | 0.140 |
Why?
|
| Cognition | 4 | 2018 | 6759 | 0.140 |
Why?
|
| Sex | 1 | 2016 | 57 | 0.140 |
Why?
|
| Peroxidase | 2 | 2016 | 611 | 0.140 |
Why?
|
| Rhinitis, Allergic, Seasonal | 3 | 2008 | 99 | 0.140 |
Why?
|
| Thyroid Diseases | 1 | 2019 | 379 | 0.140 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2019 | 549 | 0.140 |
Why?
|
| Dinoprost | 1 | 2016 | 138 | 0.140 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2010 | 4422 | 0.140 |
Why?
|
| Fructose | 1 | 2018 | 287 | 0.130 |
Why?
|
| Thyrotropin | 1 | 2019 | 850 | 0.130 |
Why?
|
| Thyroxine | 1 | 2019 | 667 | 0.130 |
Why?
|
| Health Promotion | 3 | 2023 | 2205 | 0.130 |
Why?
|
| Body Composition | 2 | 2021 | 2401 | 0.130 |
Why?
|
| Cold Temperature | 3 | 2017 | 771 | 0.130 |
Why?
|
| Smoke | 1 | 2017 | 227 | 0.130 |
Why?
|
| Microvessels | 2 | 2019 | 544 | 0.130 |
Why?
|
| Gastroesophageal Reflux | 1 | 2002 | 782 | 0.130 |
Why?
|
| Dermatophagoides farinae | 1 | 2015 | 25 | 0.130 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2018 | 168 | 0.130 |
Why?
|
| Adipokines | 1 | 2017 | 320 | 0.130 |
Why?
|
| Animals, Domestic | 3 | 2004 | 56 | 0.130 |
Why?
|
| Double-Blind Method | 5 | 2018 | 12020 | 0.130 |
Why?
|
| Aging | 8 | 2024 | 8655 | 0.130 |
Why?
|
| Psychology | 1 | 2017 | 356 | 0.130 |
Why?
|
| Family Characteristics | 3 | 2023 | 1000 | 0.130 |
Why?
|
| Sweetening Agents | 1 | 2018 | 295 | 0.130 |
Why?
|
| Biometry | 2 | 2009 | 558 | 0.130 |
Why?
|
| Interleukin-9 | 1 | 2015 | 63 | 0.130 |
Why?
|
| Administration, Inhalation | 2 | 2009 | 1105 | 0.130 |
Why?
|
| Models, Cardiovascular | 1 | 2020 | 996 | 0.130 |
Why?
|
| Pulsatile Flow | 1 | 2016 | 332 | 0.130 |
Why?
|
| Maximal Midexpiratory Flow Rate | 7 | 2013 | 78 | 0.120 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 546 | 0.120 |
Why?
|
| Seafood | 2 | 2020 | 384 | 0.120 |
Why?
|
| Vitamin B Complex | 1 | 2017 | 288 | 0.120 |
Why?
|
| Analysis of Variance | 6 | 2015 | 6356 | 0.120 |
Why?
|
| Atherosclerosis | 2 | 2022 | 3445 | 0.120 |
Why?
|
| Hospitalization | 8 | 2021 | 10259 | 0.120 |
Why?
|
| Models, Statistical | 9 | 2015 | 5100 | 0.120 |
Why?
|
| Cladosporium | 1 | 2013 | 1 | 0.120 |
Why?
|
| Coronary Artery Disease | 3 | 2009 | 6485 | 0.120 |
Why?
|
| Metals | 1 | 2018 | 719 | 0.120 |
Why?
|
| Penicillium | 1 | 2013 | 22 | 0.120 |
Why?
|
| Acute Disease | 5 | 2016 | 7150 | 0.120 |
Why?
|
| Glucose | 3 | 2017 | 4398 | 0.120 |
Why?
|
| Triticum | 1 | 2014 | 86 | 0.120 |
Why?
|
| Predictive Value of Tests | 7 | 2014 | 15067 | 0.120 |
Why?
|
| Vitamin E | 1 | 2018 | 868 | 0.120 |
Why?
|
| Glucose Intolerance | 2 | 2018 | 577 | 0.120 |
Why?
|
| Aspergillus | 1 | 2013 | 85 | 0.120 |
Why?
|
| Total Lung Capacity | 1 | 2013 | 143 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2022 | 17439 | 0.110 |
Why?
|
| Feces | 4 | 2022 | 1397 | 0.110 |
Why?
|
| Finland | 3 | 2019 | 602 | 0.110 |
Why?
|
| Nedocromil | 1 | 2013 | 46 | 0.110 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2014 | 117 | 0.110 |
Why?
|
| Papilledema | 1 | 2014 | 118 | 0.110 |
Why?
|
| C-Reactive Protein | 5 | 2022 | 3778 | 0.110 |
Why?
|
| Subcutaneous Fat | 1 | 2016 | 391 | 0.110 |
Why?
|
| Smoking | 9 | 2023 | 8984 | 0.110 |
Why?
|
| Diabetes Mellitus | 4 | 2015 | 5752 | 0.110 |
Why?
|
| Ibuprofen | 1 | 2014 | 236 | 0.110 |
Why?
|
| Disease Progression | 4 | 2019 | 13273 | 0.110 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2014 | 200 | 0.110 |
Why?
|
| Schistosomiasis mansoni | 1 | 1993 | 85 | 0.110 |
Why?
|
| Immune System | 2 | 2011 | 807 | 0.110 |
Why?
|
| Fingers | 1 | 2016 | 513 | 0.110 |
Why?
|
| Radiation Injuries | 1 | 2020 | 1180 | 0.110 |
Why?
|
| Research Design | 3 | 2019 | 5983 | 0.110 |
Why?
|
| Night Care | 1 | 1992 | 28 | 0.110 |
Why?
|
| Dilatation, Pathologic | 1 | 2014 | 520 | 0.110 |
Why?
|
| Disease Susceptibility | 5 | 2012 | 1781 | 0.110 |
Why?
|
| Beverages | 1 | 2018 | 820 | 0.100 |
Why?
|
| Acetyl-CoA C-Acyltransferase | 1 | 2011 | 22 | 0.100 |
Why?
|
| Drug Combinations | 2 | 2016 | 1958 | 0.100 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3134 | 0.100 |
Why?
|
| Recurrence | 8 | 2014 | 8337 | 0.100 |
Why?
|
| Fatigue Syndrome, Chronic | 2 | 1991 | 213 | 0.100 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3241 | 0.100 |
Why?
|
| Defibrillators, Implantable | 5 | 2015 | 1439 | 0.100 |
Why?
|
| Mitogens | 4 | 2005 | 232 | 0.100 |
Why?
|
| Genetic Variation | 3 | 2021 | 6535 | 0.100 |
Why?
|
| Ontario | 3 | 2018 | 383 | 0.100 |
Why?
|
| Community Networks | 1 | 2013 | 203 | 0.100 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2017 | 477 | 0.100 |
Why?
|
| Depression | 4 | 2021 | 7760 | 0.100 |
Why?
|
| Urbanization | 1 | 2012 | 104 | 0.100 |
Why?
|
| Family | 2 | 2017 | 3144 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 2 | 2011 | 1613 | 0.100 |
Why?
|
| Fatty Liver | 1 | 2017 | 728 | 0.100 |
Why?
|
| Enzymes | 1 | 2013 | 265 | 0.100 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2014 | 366 | 0.100 |
Why?
|
| Cluster Analysis | 2 | 2009 | 2712 | 0.100 |
Why?
|
| Monitoring, Physiologic | 2 | 2016 | 1738 | 0.100 |
Why?
|
| Orbit | 1 | 2014 | 426 | 0.100 |
Why?
|
| Autoantibodies | 1 | 2019 | 2037 | 0.100 |
Why?
|
| Papillomaviridae | 1 | 2017 | 1119 | 0.100 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2019 | 808 | 0.100 |
Why?
|
| Disabled Persons | 2 | 2001 | 1214 | 0.100 |
Why?
|
| Optic Nerve Diseases | 1 | 2014 | 327 | 0.090 |
Why?
|
| Immunoglobulin G | 3 | 2018 | 4561 | 0.090 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2009 | 361 | 0.090 |
Why?
|
| Muramic Acids | 1 | 2010 | 2 | 0.090 |
Why?
|
| Air Microbiology | 2 | 2019 | 87 | 0.090 |
Why?
|
| Diabetic Angiopathies | 2 | 2006 | 819 | 0.090 |
Why?
|
| Environment Design | 1 | 2012 | 178 | 0.090 |
Why?
|
| Acetaminophen | 1 | 2014 | 545 | 0.090 |
Why?
|
| Oximetry | 1 | 2014 | 471 | 0.090 |
Why?
|
| Chronic Disease | 5 | 2015 | 9139 | 0.090 |
Why?
|
| Optic Disk | 1 | 2014 | 400 | 0.090 |
Why?
|
| Sex Distribution | 3 | 2003 | 2298 | 0.090 |
Why?
|
| Specimen Handling | 1 | 2015 | 694 | 0.090 |
Why?
|
| Body Weight | 3 | 2018 | 4670 | 0.090 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2011 | 310 | 0.090 |
Why?
|
| Glycoproteins | 5 | 2003 | 2266 | 0.090 |
Why?
|
| Developmental Disabilities | 1 | 2019 | 1452 | 0.090 |
Why?
|
| Cesarean Section | 3 | 2022 | 1365 | 0.090 |
Why?
|
| Environment | 2 | 2014 | 1121 | 0.090 |
Why?
|
| Caregivers | 2 | 2017 | 2098 | 0.090 |
Why?
|
| Stroke | 4 | 2013 | 9975 | 0.090 |
Why?
|
| Hot Temperature | 2 | 2017 | 1351 | 0.090 |
Why?
|
| Health Personnel | 1 | 2023 | 3217 | 0.090 |
Why?
|
| Nutritional Status | 1 | 2018 | 1608 | 0.090 |
Why?
|
| Clinical Protocols | 1 | 2016 | 1459 | 0.090 |
Why?
|
| Microcirculation | 1 | 2014 | 1287 | 0.090 |
Why?
|
| Ergosterol | 1 | 2009 | 22 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2022 | 15518 | 0.090 |
Why?
|
| Interleukin-1 | 1 | 1993 | 1263 | 0.090 |
Why?
|
| Health Status Disparities | 2 | 2019 | 1796 | 0.090 |
Why?
|
| Anxiety | 2 | 2023 | 4288 | 0.090 |
Why?
|
| Ascorbic Acid | 1 | 2013 | 650 | 0.090 |
Why?
|
| Lung Diseases, Obstructive | 2 | 1989 | 315 | 0.090 |
Why?
|
| Age of Onset | 2 | 2008 | 3268 | 0.090 |
Why?
|
| Exercise | 6 | 2018 | 5611 | 0.080 |
Why?
|
| Models, Theoretical | 3 | 2016 | 3587 | 0.080 |
Why?
|
| Polysomnography | 2 | 2019 | 1776 | 0.080 |
Why?
|
| Bacterial Infections | 1 | 2017 | 1400 | 0.080 |
Why?
|
| Safety | 1 | 2014 | 1184 | 0.080 |
Why?
|
| Nursing Staff, Hospital | 1 | 1992 | 346 | 0.080 |
Why?
|
| Infant Formula | 2 | 2022 | 199 | 0.080 |
Why?
|
| Epidemiologic Research Design | 1 | 2012 | 367 | 0.080 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2009 | 165 | 0.080 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2012 | 290 | 0.080 |
Why?
|
| American Heart Association | 1 | 2013 | 1057 | 0.080 |
Why?
|
| Bronchiolitis | 1 | 2014 | 458 | 0.080 |
Why?
|
| Multicenter Studies as Topic | 2 | 2010 | 1676 | 0.080 |
Why?
|
| Lung Diseases | 4 | 2012 | 1887 | 0.080 |
Why?
|
| Work Schedule Tolerance | 1 | 1992 | 563 | 0.080 |
Why?
|
| Electrocardiography | 7 | 2017 | 6441 | 0.080 |
Why?
|
| Lipids | 1 | 2019 | 3307 | 0.080 |
Why?
|
| Occupational Diseases | 3 | 1993 | 1466 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2011 | 3874 | 0.080 |
Why?
|
| Motor Vehicles | 1 | 2009 | 268 | 0.080 |
Why?
|
| Drug Administration Schedule | 1 | 2016 | 4931 | 0.080 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2010 | 258 | 0.080 |
Why?
|
| Disaccharides | 1 | 2008 | 171 | 0.080 |
Why?
|
| New England | 2 | 2013 | 1022 | 0.070 |
Why?
|
| Executive Function | 1 | 2016 | 1361 | 0.070 |
Why?
|
| Probiotics | 1 | 2011 | 350 | 0.070 |
Why?
|
| Bronchial Provocation Tests | 2 | 2006 | 227 | 0.070 |
Why?
|
| Epithelial Cells | 2 | 2020 | 3690 | 0.070 |
Why?
|
| Intestines | 1 | 2016 | 1923 | 0.070 |
Why?
|
| World Health Organization | 1 | 2013 | 1317 | 0.070 |
Why?
|
| Membrane Glycoproteins | 3 | 2005 | 3769 | 0.070 |
Why?
|
| Pilot Projects | 5 | 2018 | 8316 | 0.070 |
Why?
|
| Peptidoglycan | 2 | 2006 | 246 | 0.070 |
Why?
|
| Health Surveys | 3 | 2019 | 4036 | 0.070 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2006 | 354 | 0.070 |
Why?
|
| Floors and Floorcoverings | 2 | 2004 | 26 | 0.070 |
Why?
|
| Brazil | 2 | 2021 | 1264 | 0.070 |
Why?
|
| Bronchoconstrictor Agents | 1 | 2006 | 77 | 0.070 |
Why?
|
| Longevity | 2 | 2023 | 1070 | 0.070 |
Why?
|
| Verbal Behavior | 1 | 1988 | 340 | 0.070 |
Why?
|
| Insulin Resistance | 1 | 2020 | 3863 | 0.070 |
Why?
|
| Lipopolysaccharides | 3 | 2017 | 2217 | 0.070 |
Why?
|
| United States Environmental Protection Agency | 2 | 2019 | 139 | 0.070 |
Why?
|
| Bone Density | 1 | 2019 | 3460 | 0.070 |
Why?
|
| Data Collection | 2 | 2002 | 3339 | 0.070 |
Why?
|
| Interleukin-2 | 1 | 1993 | 1904 | 0.070 |
Why?
|
| Vascular Diseases | 1 | 2015 | 1161 | 0.070 |
Why?
|
| Methacholine Chloride | 1 | 2006 | 233 | 0.070 |
Why?
|
| Surface-Active Agents | 1 | 1986 | 159 | 0.070 |
Why?
|
| Genotype | 6 | 2023 | 12944 | 0.070 |
Why?
|
| Reference Values | 4 | 2012 | 4974 | 0.070 |
Why?
|
| Cell Separation | 1 | 2011 | 1750 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2018 | 3482 | 0.070 |
Why?
|
| Risk | 5 | 2019 | 9677 | 0.070 |
Why?
|
| Mortality | 3 | 2020 | 2862 | 0.070 |
Why?
|
| 5' Flanking Region | 1 | 2005 | 31 | 0.070 |
Why?
|
| Respiration Disorders | 1 | 1989 | 371 | 0.070 |
Why?
|
| Cardiovascular System | 1 | 2013 | 828 | 0.070 |
Why?
|
| Retrospective Studies | 12 | 2019 | 77410 | 0.070 |
Why?
|
| Cost-Benefit Analysis | 2 | 2017 | 5388 | 0.070 |
Why?
|
| Suburban Population | 1 | 2005 | 55 | 0.070 |
Why?
|
| Polysorbates | 1 | 2005 | 41 | 0.070 |
Why?
|
| Papillomavirus Infections | 1 | 2017 | 1587 | 0.070 |
Why?
|
| Receptors, Cell Surface | 2 | 2005 | 2865 | 0.060 |
Why?
|
| Acute Coronary Syndrome | 2 | 2009 | 2337 | 0.060 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 5319 | 0.060 |
Why?
|
| Meteorological Concepts | 1 | 2004 | 30 | 0.060 |
Why?
|
| Heme Oxygenase-1 | 1 | 2007 | 381 | 0.060 |
Why?
|
| Peripheral Arterial Disease | 1 | 2016 | 1188 | 0.060 |
Why?
|
| Herpesvirus 4, Human | 1 | 1990 | 1041 | 0.060 |
Why?
|
| Vasoconstriction | 2 | 2005 | 597 | 0.060 |
Why?
|
| Toll-Like Receptors | 2 | 2005 | 593 | 0.060 |
Why?
|
| Russia | 1 | 2005 | 408 | 0.060 |
Why?
|
| Gastrointestinal Tract | 1 | 2011 | 814 | 0.060 |
Why?
|
| Sequence Analysis, RNA | 3 | 2018 | 2009 | 0.060 |
Why?
|
| Angina, Unstable | 1 | 2009 | 926 | 0.060 |
Why?
|
| Hygiene | 1 | 2005 | 97 | 0.060 |
Why?
|
| Weight Gain | 1 | 2015 | 2294 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2281 | 0.060 |
Why?
|
| Mexican Americans | 1 | 2005 | 165 | 0.060 |
Why?
|
| Birth Order | 1 | 2005 | 95 | 0.060 |
Why?
|
| Androstadienes | 1 | 2006 | 345 | 0.060 |
Why?
|
| DNA, Mitochondrial | 2 | 2021 | 815 | 0.060 |
Why?
|
| Arizona | 1 | 2004 | 108 | 0.060 |
Why?
|
| Biodiversity | 2 | 2017 | 341 | 0.060 |
Why?
|
| Severity of Illness Index | 4 | 2021 | 15526 | 0.060 |
Why?
|
| Statistics as Topic | 2 | 2003 | 2369 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2002 | 7172 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 9440 | 0.060 |
Why?
|
| Fungal Structures | 1 | 2003 | 2 | 0.060 |
Why?
|
| Students | 4 | 2015 | 1647 | 0.060 |
Why?
|
| Chicago | 1 | 2004 | 240 | 0.060 |
Why?
|
| Drug Resistance | 1 | 2009 | 1606 | 0.060 |
Why?
|
| Washington | 1 | 2004 | 314 | 0.060 |
Why?
|
| Denmark | 2 | 2018 | 738 | 0.060 |
Why?
|
| Body Height | 3 | 2008 | 1579 | 0.060 |
Why?
|
| Filtration | 2 | 2017 | 233 | 0.060 |
Why?
|
| Texas | 1 | 2004 | 390 | 0.060 |
Why?
|
| Blood Gas Analysis | 1 | 2004 | 383 | 0.060 |
Why?
|
| Infant Equipment | 1 | 2002 | 24 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2017 | 6259 | 0.050 |
Why?
|
| Herpes Simplex | 1 | 1986 | 470 | 0.050 |
Why?
|
| Manometry | 2 | 2016 | 445 | 0.050 |
Why?
|
| Self Report | 3 | 2022 | 3550 | 0.050 |
Why?
|
| Vasculitis | 1 | 2006 | 519 | 0.050 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2022 | 130 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 2010 | 1403 | 0.050 |
Why?
|
| Polymorphism, Genetic | 3 | 2013 | 4326 | 0.050 |
Why?
|
| Costa Rica | 2 | 2015 | 177 | 0.050 |
Why?
|
| Systole | 1 | 2004 | 958 | 0.050 |
Why?
|
| Diastole | 1 | 2004 | 791 | 0.050 |
Why?
|
| Circadian Rhythm | 2 | 1999 | 2620 | 0.050 |
Why?
|
| Rodenticides | 1 | 2021 | 21 | 0.050 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2006 | 1240 | 0.050 |
Why?
|
| New York City | 1 | 2004 | 705 | 0.050 |
Why?
|
| Cough | 2 | 2003 | 555 | 0.050 |
Why?
|
| Cryptosporidium | 1 | 2002 | 45 | 0.050 |
Why?
|
| Milk Proteins | 1 | 2022 | 167 | 0.050 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2009 | 1874 | 0.050 |
Why?
|
| Soil Microbiology | 1 | 2002 | 87 | 0.050 |
Why?
|
| Population Density | 1 | 2002 | 196 | 0.050 |
Why?
|
| Linkage Disequilibrium | 2 | 2020 | 1996 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2017 | 3308 | 0.050 |
Why?
|
| Probability | 2 | 2002 | 2505 | 0.050 |
Why?
|
| Eggs | 1 | 2022 | 184 | 0.050 |
Why?
|
| Sulfonic Acids | 1 | 2021 | 97 | 0.050 |
Why?
|
| Epidemiologic Studies | 1 | 2005 | 676 | 0.050 |
Why?
|
| Metagenome | 2 | 2017 | 418 | 0.050 |
Why?
|
| Brain Ischemia | 2 | 2013 | 3264 | 0.050 |
Why?
|
| Intestinal Mucosa | 1 | 2012 | 3038 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2011 | 5973 | 0.050 |
Why?
|
| Neutrophils | 1 | 2013 | 3718 | 0.050 |
Why?
|
| Anaphylaxis | 1 | 2008 | 746 | 0.050 |
Why?
|
| Polyethylene Glycols | 1 | 1986 | 1181 | 0.050 |
Why?
|
| Missouri | 2 | 2007 | 117 | 0.050 |
Why?
|
| Water Supply | 1 | 2002 | 214 | 0.050 |
Why?
|
| Immunization, Passive | 1 | 2003 | 623 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2020 | 9944 | 0.050 |
Why?
|
| Workers' Compensation | 1 | 2001 | 152 | 0.050 |
Why?
|
| Heart Ventricles | 2 | 2011 | 3817 | 0.050 |
Why?
|
| Educational Status | 4 | 2018 | 2540 | 0.040 |
Why?
|
| Antibodies, Viral | 2 | 1991 | 3175 | 0.040 |
Why?
|
| Proportional Hazards Models | 3 | 2022 | 12354 | 0.040 |
Why?
|
| Mental Health | 1 | 2014 | 3012 | 0.040 |
Why?
|
| Zinc | 1 | 2024 | 683 | 0.040 |
Why?
|
| Smog | 1 | 1999 | 4 | 0.040 |
Why?
|
| Blood Vessels | 1 | 2005 | 1124 | 0.040 |
Why?
|
| Quantitative Trait Loci | 2 | 2020 | 2018 | 0.040 |
Why?
|
| Absenteeism | 1 | 2001 | 250 | 0.040 |
Why?
|
| Rest | 1 | 2004 | 901 | 0.040 |
Why?
|
| Genomics | 1 | 2015 | 5714 | 0.040 |
Why?
|
| Thailand | 1 | 2000 | 299 | 0.040 |
Why?
|
| Comorbidity | 2 | 2004 | 10380 | 0.040 |
Why?
|
| Superior Sagittal Sinus | 1 | 2018 | 17 | 0.040 |
Why?
|
| Hospital Bed Capacity | 1 | 2020 | 215 | 0.040 |
Why?
|
| Forecasting | 2 | 2005 | 2950 | 0.040 |
Why?
|
| Fatty Acids, Volatile | 1 | 2019 | 102 | 0.040 |
Why?
|
| Culex | 3 | 1969 | 17 | 0.040 |
Why?
|
| Plant Extracts | 1 | 2022 | 471 | 0.040 |
Why?
|
| Nutrition Policy | 1 | 2023 | 488 | 0.040 |
Why?
|
| Neoplasm Proteins | 2 | 2022 | 3706 | 0.040 |
Why?
|
| Life Change Events | 1 | 2004 | 938 | 0.040 |
Why?
|
| Social Environment | 1 | 2004 | 1022 | 0.040 |
Why?
|
| Reproducibility of Results | 4 | 2023 | 19894 | 0.040 |
Why?
|
| Clostridium | 1 | 2018 | 98 | 0.040 |
Why?
|
| Bacteroides | 1 | 2018 | 161 | 0.040 |
Why?
|
| Bifidobacterium | 1 | 2018 | 100 | 0.040 |
Why?
|
| Milk, Human | 1 | 2022 | 490 | 0.040 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2018 | 117 | 0.040 |
Why?
|
| Health Benefit Plans, Employee | 1 | 2001 | 332 | 0.040 |
Why?
|
| Antibody Formation | 1 | 2003 | 1402 | 0.040 |
Why?
|
| Myocardial Infarction | 3 | 2009 | 11708 | 0.040 |
Why?
|
| Respiratory Mechanics | 2 | 2010 | 686 | 0.040 |
Why?
|
| Acinetobacter | 1 | 2017 | 39 | 0.040 |
Why?
|
| Cell Proliferation | 4 | 2006 | 10477 | 0.040 |
Why?
|
| Iodide Peroxidase | 1 | 2019 | 293 | 0.040 |
Why?
|
| Exercise Therapy | 1 | 2004 | 904 | 0.040 |
Why?
|
| Intelligence Tests | 1 | 2018 | 503 | 0.040 |
Why?
|
| Lead | 2 | 2021 | 852 | 0.040 |
Why?
|
| Switzerland | 2 | 2008 | 255 | 0.040 |
Why?
|
| Radiation Monitoring | 1 | 2018 | 98 | 0.040 |
Why?
|
| Bacteroides fragilis | 1 | 2018 | 212 | 0.040 |
Why?
|
| Otitis Media | 1 | 1999 | 277 | 0.040 |
Why?
|
| Models, Biological | 2 | 2012 | 9582 | 0.040 |
Why?
|
| Causality | 1 | 2003 | 1275 | 0.040 |
Why?
|
| Up-Regulation | 2 | 2017 | 4221 | 0.040 |
Why?
|
| Population | 1 | 2017 | 141 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2017 | 3921 | 0.040 |
Why?
|
| Heart | 2 | 2008 | 4460 | 0.040 |
Why?
|
| Observer Variation | 1 | 2003 | 2592 | 0.040 |
Why?
|
| DNA, Ribosomal | 1 | 2017 | 290 | 0.040 |
Why?
|
| Tachycardia, Ventricular | 1 | 2005 | 1272 | 0.030 |
Why?
|
| Cattle | 1 | 2022 | 3917 | 0.030 |
Why?
|
| Infant, Premature | 2 | 2004 | 2031 | 0.030 |
Why?
|
| Thinness | 1 | 2019 | 480 | 0.030 |
Why?
|
| Aerosols | 1 | 2018 | 623 | 0.030 |
Why?
|
| Maternal Age | 3 | 2007 | 802 | 0.030 |
Why?
|
| Arteries | 1 | 2021 | 1119 | 0.030 |
Why?
|
| Quality of Life | 1 | 2017 | 12788 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2019 | 917 | 0.030 |
Why?
|
| Eosinophil Major Basic Protein | 1 | 2015 | 14 | 0.030 |
Why?
|
| Schistosoma mansoni | 2 | 1993 | 149 | 0.030 |
Why?
|
| Fathers | 1 | 1998 | 358 | 0.030 |
Why?
|
| Telomere | 1 | 2021 | 910 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2021 | 1158 | 0.030 |
Why?
|
| Cytomegalovirus | 2 | 1990 | 733 | 0.030 |
Why?
|
| Body Size | 1 | 2018 | 461 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2004 | 2500 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 2017 | 1095 | 0.030 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2017 | 370 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2017 | 357 | 0.030 |
Why?
|
| Prognosis | 4 | 2020 | 29052 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2005 | 1859 | 0.030 |
Why?
|
| Immunity | 1 | 2021 | 1013 | 0.030 |
Why?
|
| Natural Killer T-Cells | 1 | 2018 | 316 | 0.030 |
Why?
|
| Attitude to Health | 1 | 2004 | 2052 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 2017 | 793 | 0.030 |
Why?
|
| Pregnancy Outcome | 2 | 2016 | 2794 | 0.030 |
Why?
|
| Interleukin-5 | 1 | 2015 | 273 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2021 | 1660 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 2021 | 1237 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2002 | 3912 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2018 | 975 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 2008 | 9272 | 0.030 |
Why?
|
| Pulse | 1 | 2014 | 228 | 0.030 |
Why?
|
| Developed Countries | 1 | 2017 | 437 | 0.030 |
Why?
|
| Psychometrics | 1 | 2023 | 3000 | 0.030 |
Why?
|
| Spleen | 3 | 2004 | 2359 | 0.030 |
Why?
|
| Puerto Rico | 1 | 2015 | 356 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 715 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2020 | 1531 | 0.030 |
Why?
|
| Infant Mortality | 1 | 1999 | 755 | 0.030 |
Why?
|
| Metagenomics | 1 | 2017 | 428 | 0.030 |
Why?
|
| Nebulizers and Vaporizers | 1 | 1994 | 139 | 0.030 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2017 | 449 | 0.030 |
Why?
|
| Kansas | 1 | 1993 | 39 | 0.030 |
Why?
|
| Antigens, Helminth | 1 | 1993 | 64 | 0.030 |
Why?
|
| New York | 2 | 2011 | 885 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 13112 | 0.030 |
Why?
|
| Tennessee | 1 | 1993 | 117 | 0.030 |
Why?
|
| Wisconsin | 1 | 1993 | 124 | 0.030 |
Why?
|
| Membrane Proteins | 2 | 2021 | 7880 | 0.030 |
Why?
|
| Medical Audit | 1 | 2015 | 466 | 0.030 |
Why?
|
| Peritoneal Cavity | 1 | 1993 | 148 | 0.030 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2013 | 46 | 0.030 |
Why?
|
| Ascorbic Acid Deficiency | 1 | 2013 | 24 | 0.030 |
Why?
|
| Respiration | 1 | 2000 | 1653 | 0.030 |
Why?
|
| Poverty Areas | 1 | 2015 | 275 | 0.030 |
Why?
|
| Colony Count, Microbial | 1 | 2013 | 331 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2021 | 1937 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2014 | 513 | 0.030 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2013 | 97 | 0.030 |
Why?
|
| Micronutrients | 1 | 2016 | 375 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 1993 | 352 | 0.030 |
Why?
|
| Schistosomiasis | 1 | 1993 | 62 | 0.030 |
Why?
|
| Patient Admission | 1 | 2000 | 1380 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 4459 | 0.030 |
Why?
|
| Income | 2 | 2000 | 1913 | 0.030 |
Why?
|
| Aftercare | 1 | 1999 | 870 | 0.030 |
Why?
|
| Gastroenterology | 1 | 1999 | 538 | 0.030 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2016 | 378 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2017 | 1463 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2016 | 1004 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2016 | 63042 | 0.030 |
Why?
|
| Legionnaires' Disease | 1 | 1992 | 48 | 0.030 |
Why?
|
| Food | 1 | 2017 | 771 | 0.030 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2017 | 875 | 0.030 |
Why?
|
| Anthropometry | 1 | 2017 | 1348 | 0.030 |
Why?
|
| Primary Prevention | 1 | 2000 | 1167 | 0.030 |
Why?
|
| Anxiety Disorders | 1 | 2023 | 2684 | 0.030 |
Why?
|
| Testis | 1 | 1995 | 795 | 0.030 |
Why?
|
| Case-Control Studies | 3 | 2018 | 21733 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2001 | 2540 | 0.030 |
Why?
|
| Insect Bites and Stings | 3 | 1969 | 67 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 2014 | 980 | 0.030 |
Why?
|
| Alveolitis, Extrinsic Allergic | 1 | 1992 | 61 | 0.030 |
Why?
|
| Sensitivity and Specificity | 3 | 2014 | 14714 | 0.030 |
Why?
|
| Growth | 1 | 1993 | 376 | 0.030 |
Why?
|
| Public Health | 1 | 2005 | 2603 | 0.030 |
Why?
|
| Intra-Abdominal Fat | 1 | 2016 | 591 | 0.020 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2017 | 985 | 0.020 |
Why?
|
| Entamoeba histolytica | 2 | 1981 | 30 | 0.020 |
Why?
|
| Alleles | 1 | 2022 | 6934 | 0.020 |
Why?
|
| Kidney | 3 | 2021 | 7185 | 0.020 |
Why?
|
| Skinfold Thickness | 1 | 2011 | 162 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 2203 | 0.020 |
Why?
|
| Dietary Carbohydrates | 1 | 2016 | 906 | 0.020 |
Why?
|
| Dietary Proteins | 1 | 2016 | 962 | 0.020 |
Why?
|
| Formaldehyde | 1 | 1992 | 353 | 0.020 |
Why?
|
| Baltimore | 1 | 2011 | 230 | 0.020 |
Why?
|
| BCG Vaccine | 1 | 1993 | 369 | 0.020 |
Why?
|
| Creatinine | 1 | 2016 | 1918 | 0.020 |
Why?
|
| Walking | 1 | 1998 | 1182 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2017 | 1018 | 0.020 |
Why?
|
| Eosinophilia | 1 | 2015 | 541 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 1993 | 559 | 0.020 |
Why?
|
| Chi-Square Distribution | 2 | 2007 | 3503 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2014 | 1423 | 0.020 |
Why?
|
| Cholesterol | 1 | 2019 | 2922 | 0.020 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 1989 | 74 | 0.020 |
Why?
|
| Geographic Information Systems | 1 | 2012 | 281 | 0.020 |
Why?
|
| Dehydrocholesterols | 1 | 2009 | 20 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 2 | 2012 | 2715 | 0.020 |
Why?
|
| Herpesvirus 6, Human | 1 | 1990 | 95 | 0.020 |
Why?
|
| Th1 Cells | 2 | 2005 | 1057 | 0.020 |
Why?
|
| Th2 Cells | 2 | 2005 | 1061 | 0.020 |
Why?
|
| Prenatal Care | 1 | 2017 | 1092 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2018 | 1373 | 0.020 |
Why?
|
| Maternal-Fetal Relations | 1 | 2009 | 25 | 0.020 |
Why?
|
| Autoimmune Diseases | 1 | 2001 | 2134 | 0.020 |
Why?
|
| Growth Disorders | 1 | 1994 | 645 | 0.020 |
Why?
|
| Cells, Cultured | 3 | 2015 | 19232 | 0.020 |
Why?
|
| Pre-Eclampsia | 1 | 2018 | 1200 | 0.020 |
Why?
|
| Encephalitis | 1 | 2012 | 424 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2001 | 5096 | 0.020 |
Why?
|
| Mitochondria | 1 | 2021 | 3513 | 0.020 |
Why?
|
| Carbon Isotopes | 1 | 2009 | 468 | 0.020 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 1992 | 499 | 0.020 |
Why?
|
| Antigens, Bacterial | 1 | 2014 | 1172 | 0.020 |
Why?
|
| Adjuvants, Immunologic | 1 | 1993 | 999 | 0.020 |
Why?
|
| Premature Birth | 1 | 2020 | 1722 | 0.020 |
Why?
|
| Child, Hospitalized | 1 | 1989 | 174 | 0.020 |
Why?
|
| Sputum | 1 | 2010 | 476 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 1999 | 2119 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2019 | 3280 | 0.020 |
Why?
|
| Isotope Labeling | 1 | 2009 | 405 | 0.020 |
Why?
|
| Ischemia | 1 | 2016 | 1907 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2010 | 690 | 0.020 |
Why?
|
| Multiple Sclerosis | 2 | 2001 | 3079 | 0.020 |
Why?
|
| Homeostasis | 1 | 2017 | 3337 | 0.020 |
Why?
|
| Rural Population | 1 | 2017 | 2207 | 0.020 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2006 | 42 | 0.020 |
Why?
|
| Limulus Test | 1 | 2005 | 19 | 0.020 |
Why?
|
| Work | 1 | 2007 | 191 | 0.020 |
Why?
|
| Cross Reactions | 1 | 2008 | 841 | 0.020 |
Why?
|
| Hypersensitivity, Delayed | 2 | 1969 | 484 | 0.020 |
Why?
|
| Medication Errors | 1 | 1992 | 798 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2010 | 1588 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 1999 | 3530 | 0.020 |
Why?
|
| Psychological Tests | 1 | 1988 | 647 | 0.020 |
Why?
|
| Brain | 1 | 2012 | 26345 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2019 | 20121 | 0.020 |
Why?
|
| Reference Standards | 1 | 2009 | 1023 | 0.020 |
Why?
|
| Infant, Low Birth Weight | 1 | 2010 | 848 | 0.020 |
Why?
|
| Microsatellite Repeats | 1 | 2007 | 799 | 0.020 |
Why?
|
| Bronchi | 1 | 1989 | 840 | 0.020 |
Why?
|
| Osteoporosis | 1 | 2015 | 1577 | 0.020 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2006 | 200 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 13691 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2011 | 3585 | 0.020 |
Why?
|
| Lipid A | 1 | 2004 | 67 | 0.020 |
Why?
|
| Interview, Psychological | 1 | 1988 | 812 | 0.020 |
Why?
|
| Phytohemagglutinins | 1 | 2004 | 170 | 0.020 |
Why?
|
| Personality | 1 | 1988 | 552 | 0.010 |
Why?
|
| Infant Welfare | 1 | 2004 | 81 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1996 | 10940 | 0.010 |
Why?
|
| Diagnosis | 1 | 1965 | 154 | 0.010 |
Why?
|
| Beds | 1 | 2004 | 48 | 0.010 |
Why?
|
| Urography | 1 | 1965 | 313 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 9648 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2006 | 595 | 0.010 |
Why?
|
| Emergency Medical Services | 1 | 2015 | 1917 | 0.010 |
Why?
|
| Germany | 1 | 2005 | 862 | 0.010 |
Why?
|
| Cytomegalovirus Infections | 1 | 1989 | 820 | 0.010 |
Why?
|
| Antigens, Differentiation | 1 | 2006 | 927 | 0.010 |
Why?
|
| T-Lymphocytes | 3 | 1990 | 10179 | 0.010 |
Why?
|
| von Willebrand Factor | 1 | 2006 | 669 | 0.010 |
Why?
|
| Clinical Trials as Topic | 2 | 2011 | 7908 | 0.010 |
Why?
|
| Medicare | 1 | 2000 | 6565 | 0.010 |
Why?
|
| Registries | 1 | 2018 | 8090 | 0.010 |
Why?
|
| Graft Rejection | 1 | 1995 | 4398 | 0.010 |
Why?
|
| Oocysts | 1 | 2002 | 20 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 5867 | 0.010 |
Why?
|
| Health Behavior | 1 | 2014 | 2634 | 0.010 |
Why?
|
| Immune System Diseases | 1 | 2004 | 261 | 0.010 |
Why?
|
| Plant Roots | 1 | 2002 | 109 | 0.010 |
Why?
|
| Ownership | 1 | 2004 | 332 | 0.010 |
Why?
|
| Connecticut | 1 | 2002 | 366 | 0.010 |
Why?
|
| Mass Screening | 1 | 2017 | 5251 | 0.010 |
Why?
|
| Arteriovenous Fistula | 1 | 1965 | 315 | 0.010 |
Why?
|
| Epitopes | 1 | 2008 | 2570 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2014 | 5986 | 0.010 |
Why?
|
| Antigens | 2 | 2006 | 1466 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2021 | 12209 | 0.010 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2004 | 567 | 0.010 |
Why?
|
| Travel | 1 | 2006 | 788 | 0.010 |
Why?
|
| Telecommunications | 1 | 2001 | 80 | 0.010 |
Why?
|
| Agriculture | 1 | 2002 | 186 | 0.010 |
Why?
|
| Rats | 1 | 2017 | 24250 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2013 | 10251 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2008 | 4009 | 0.010 |
Why?
|
| Environment, Controlled | 1 | 1999 | 46 | 0.010 |
Why?
|
| Utah | 1 | 1999 | 126 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2009 | 2455 | 0.010 |
Why?
|
| Medical Records | 1 | 2005 | 1412 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2006 | 2538 | 0.010 |
Why?
|
| Angiography | 1 | 1965 | 1638 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2014 | 7729 | 0.010 |
Why?
|
| Nephrectomy | 1 | 1965 | 1048 | 0.010 |
Why?
|
| Hospitals | 1 | 1992 | 3953 | 0.010 |
Why?
|
| Depressive Disorder | 1 | 1991 | 3744 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2009 | 2750 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2011 | 2988 | 0.010 |
Why?
|
| Electric Countershock | 1 | 2000 | 534 | 0.010 |
Why?
|
| Vegetables | 1 | 2002 | 1181 | 0.010 |
Why?
|
| Sertoli Cells | 1 | 1995 | 49 | 0.010 |
Why?
|
| Israel | 3 | 1969 | 796 | 0.010 |
Why?
|
| Protein Binding | 1 | 2008 | 9377 | 0.010 |
Why?
|
| Common Cold | 1 | 1995 | 61 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2006 | 4026 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 1995 | 216 | 0.010 |
Why?
|
| Tissue Transplantation | 1 | 1995 | 129 | 0.010 |
Why?
|
| Philadelphia | 1 | 1995 | 267 | 0.010 |
Why?
|
| Long-Term Care | 1 | 1999 | 606 | 0.010 |
Why?
|
| Workload | 1 | 2001 | 849 | 0.010 |
Why?
|
| Workplace | 1 | 2001 | 836 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1997 | 2050 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2015 | 8035 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 1965 | 2146 | 0.010 |
Why?
|
| Proteins | 1 | 2009 | 6098 | 0.010 |
Why?
|
| Antibodies, Helminth | 1 | 1993 | 50 | 0.010 |
Why?
|
| Hepatomegaly | 1 | 1993 | 85 | 0.010 |
Why?
|
| Psoriasis | 1 | 2001 | 901 | 0.010 |
Why?
|
| Immunoglobulin Idiotypes | 1 | 1993 | 201 | 0.010 |
Why?
|
| Splenomegaly | 1 | 1993 | 190 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1993 | 448 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 1997 | 13028 | 0.010 |
Why?
|
| Algorithms | 1 | 2011 | 13869 | 0.010 |
Why?
|
| DNA Primers | 1 | 1995 | 2891 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 2 | 1995 | 6380 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 2 | 1981 | 370 | 0.010 |
Why?
|
| Antibodies, Protozoan | 1 | 1991 | 253 | 0.010 |
Why?
|
| Body Constitution | 1 | 1990 | 278 | 0.010 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 1989 | 156 | 0.010 |
Why?
|
| Hospitals, Pediatric | 1 | 1999 | 1775 | 0.010 |
Why?
|
| Microglia | 1 | 1997 | 1267 | 0.010 |
Why?
|
| Mutation | 1 | 2013 | 29777 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 1999 | 2760 | 0.000 |
Why?
|
| Airway Resistance | 1 | 1989 | 404 | 0.000 |
Why?
|
| Ambulatory Care | 1 | 1999 | 2707 | 0.000 |
Why?
|
| Minority Groups | 1 | 1995 | 1222 | 0.000 |
Why?
|
| Health Care Costs | 1 | 2001 | 3207 | 0.000 |
Why?
|
| Syndrome | 1 | 1993 | 3249 | 0.000 |
Why?
|
| Pericardiectomy | 1 | 1966 | 45 | 0.000 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2001 | 3712 | 0.000 |
Why?
|
| Survival Rate | 1 | 2000 | 12786 | 0.000 |
Why?
|
| Pericarditis | 1 | 1966 | 128 | 0.000 |
Why?
|
| Base Sequence | 1 | 1995 | 12798 | 0.000 |
Why?
|
| Desensitization, Immunologic | 1 | 1969 | 483 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 11360 | 0.000 |
Why?
|
| Macrophages | 1 | 1997 | 5651 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1995 | 18107 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2004 | 23398 | 0.000 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 1991 | 6030 | 0.000 |
Why?
|
| Health Status | 1 | 1993 | 4031 | 0.000 |
Why?
|
| Mice, Inbred C3H | 1 | 1980 | 964 | 0.000 |
Why?
|
| Apoptosis | 1 | 1995 | 9718 | 0.000 |
Why?
|
| Immunoglobulins | 1 | 1981 | 881 | 0.000 |
Why?
|
| Liver | 1 | 1993 | 7479 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1991 | 12954 | 0.000 |
Why?
|
| Mice, Nude | 1 | 1980 | 3680 | 0.000 |
Why?
|
| B-Lymphocytes | 1 | 1980 | 4665 | 0.000 |
Why?
|
| Neoplasms | 1 | 1993 | 21675 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 1966 | 15281 | 0.000 |
Why?
|